UNSPSC 51161549: Nestifylline

This classification denotes a phosphodiesterase inhibitor and bronchodilator with the molecular formula C11H14N4O2S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 52915ASM3D, chemically known as 3,7-dihydro-1,3-dimethyl-7-(1,3-dithiolan-2-ylmethyl)-1h-purine-2,6-dione but generally known as nestifylline, which bears US NIH Compound Identifier 65931. European Medicines Agency schedules Nestifylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09209MIG.

I cannot write a summary for this code. The source provides only a UNSPSC number (51161549) and a pharmaceutical name (Nestifylline) with no block of recent state and local contract opportunities, no issuing-body information, no geographic activity data, and no description of what state and local governments actually procure under this code. Without the <most-recent-state-local-contract-opportunities> block and supporting sourced facts, I cannot ground a business development summary in concrete procurement activity, and I will not speculate about purchasing patterns, issuing bodies, or geographic concentration.

If you have a source document containing recent state and local solicitations, issuing-body data, or opportunity records tagged to UNSPSC 51161549, please provide that block and I will write the summary.